Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
56.23B | 52.38B | 46.39B | 41.66B | 43.47B | Gross Profit |
11.69B | 10.90B | 8.27B | 6.87B | 6.01B | EBIT |
2.58B | 2.48B | 2.60B | 1.15B | -337.00M | EBITDA |
5.93B | 6.39B | 7.59B | 4.80B | 3.65B | Net Income Common Stockholders |
752.00M | 2.20B | -338.00M | 888.00M | -8.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
23.07B | 20.20B | 22.36B | 22.82B | 22.12B | Total Assets |
129.37B | 121.91B | 118.32B | 113.74B | 115.74B | Total Debt |
9.57B | 65.08B | 64.34B | 61.96B | 64.89B | Net Debt |
-12.97B | 45.39B | 42.57B | 40.03B | 43.20B | Total Liabilities |
98.26B | 91.28B | 88.78B | 85.85B | 90.40B | Stockholders Equity |
30.31B | 29.75B | 28.80B | 27.32B | 24.77B |
Cash Flow | Free Cash Flow | |||
4.11B | 1.40B | 929.00M | -277.00M | 1.54B | Operating Cash Flow |
7.16B | 4.46B | 3.61B | 2.41B | 5.75B | Investing Cash Flow |
-2.04B | -2.23B | -3.24B | -1.62B | -4.23B | Financing Cash Flow |
-3.23B | -3.08B | -532.00M | -629.00M | 5.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €1.83B | 12.53 | 2.80% | 3.80% | 6.78% | 7.28% | |
74 Outperform | €2.22B | 13.68 | 4.44% | 4.61% | -2.50% | -26.84% | |
67 Neutral | $22.70B | 12.13 | 10.41% | 4.29% | -4.06% | -4.47% | |
66 Neutral | $4.49B | 12.22 | 5.40% | 3.71% | 4.17% | -11.97% | |
61 Neutral | €11.38B | 14.23 | 2.50% | 5.60% | 7.36% | -64.31% | |
60 Neutral | €1.64B | 10.39 | -4.21% | 6.00% | -1.00% | -181.16% |